webinar register page

Pathology Grand Rounds November 2021- Sponsored by PathSoc & The Jean Shanks Foundation
Title: 'Applying single-cell technologies in nephropathology'

Prof Menna Clatworthy, University of Cambridge

Menna Clatworthy read Medicine at Cardiff, completed her professional training in nephrology at Cambridge, and undertook a PhD at the University of Cambridge investigating IgG effector function in autoimmunity and infection. She was awarded the British Renal Association Raine Award and the Academy of Medical Sciences/Medical Research Society Young Investigator Award for this work. She subsequently completed a Wellcome Trust Intermediate Fellowship at Cambridge and the National Institutes of Health, Bethesda, USA.
She is currently the Professor of Translational Immunology at the University of Cambridge Department of Medicine. She also works clinically as an Honorary Consultant Nephrologist and holds an Associate Faculty position in Cellular Genetics at the Wellcome Sanger Institute. Her research is focused on understanding the regulation of antibody generation and effector function, novel methods of targeting humoral immunity in transplantation and autoimmunity and the role of tissue-environment in shaping resident immune cell activation and function, particularly in the kidney. She also an active participant in the Human Cell Atlas Project (https://www.humancellatlas.org), utilizing single cell technologies to better understand the cellular landscape of the human kidney.

Session Chair- Professor Mark Arends

Nov 17, 2021 09:00 AM in London

Webinar logo
* Required information
Loading

Speakers

Dr Anita Grigoriadis
Non-Clinical Deputy Head for the Breast Cancer Now Unit @King's College London
Anita Grigoriadis is the Non-Clinical Deputy Head for the Breast Cancer Now Unit, and a Reader in Cancer Bioinformatics at King’s College London, London UK. After finishing her degree at the Institute of Molecular Pathology, University of Vienna (Austria), Anita pursued a joint PhD between the Ludwig Institute for Cancer Research, London UK and Faculty of Natural Sciences, Salzburg Austria. Anita conducted her postdoctoral training on breast cancer genomics with Professor Alan Ashworth at Breakthrough Breast Cancer Centre (London). In 2008, she joined the Breast Cancer NOW Unit (formerly Breakthrough Breast Cancer Research) at King’s under the leadership of Professor Andrew Tutt, and started her own team in 2013. Currently, Anita is a committee member of the CRUK City of London Centre Executive Board, The Clinical Trial Pathology Advisory Group of the Cellular Molecular Pathology (NCRI programme), and recently the Research Subcommittee of the Pathological Society.
Professor Adrienne Flanagn
@University College of London
The session will be chaired by Professor Adrienne Flanagan.
Dr Lucy Yates
Clinical Career Development Fellow at the Wellcome Sanger Institute @Wellcome Sanger Institute, Cambridge
Lucy Yates is a Clinical Career Development Fellow at the Wellcome Sanger Institute. Lucy trained as a clinical oncologist in London, UK and attained a PhD in cancer genomics and evolution from the Wellcome Sanger Institute and the University of Cambridge. Her research program is focused on understanding the evolutionary mechanisms underlying cancer onset, growth and progression. This is achieved by employing a range of genomic and spatial profiling techniques and developing computational approaches that facilitate the integration and modelling of multi-layered datasets.